Skip to main content
  • Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics

    About The Event

    This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
    At the conclusion of this course, participants will be able to:
    - Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
    - Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
    - Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
    - Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT


    Date and Time: On Thu, 09 May 2024 07:30 - Fri, 10 May 2024 16:45

    Category: Conferences | Science, Health and Medicine | Radiology

    Practicing Physician/Industry: USD 1395.00,
    Military/Retired/Scientist/VA: USD 1295.00,
    PA/Nurse: USD 1195.00,
    Resident*/Fellow*: USD 1095.00,
    Technologist: USD 995.00

    Speakers: Phillip Kuo, MD, PhD, FACR, Andrew Quon, MD, Don Yoo, MD

    Wynn Las Vegas, 3131 Las Vegas Boulevard South, Las Vegas, Nevada, 89109, United States


Privacy Policy:


By using this site, you agree to the Privacy Policy and acknowledge the use of cookies to store information, which may be essential to making our site work properly or enhancing user experience.